Polyrizon Ltd. Ordinary Shares
Symbol: PLRZ (NASDAQ)
1.06
▼ (-5.36%) -0.060
Company Description:
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.
Key Stats
- Today's Open: $1.09
- Today's High: $1.165
- Today's Low: $1.06
- Today's Volume: 631.65K
- Yesterday Close: $1.12
- Yesterday High: $1.22
- Yesterday Low: $1.01
- Yesterday Volume: 3.05M
- Last Min Volume: 200
- Last Min High: $1.06
- Last Min Low: $1.06
- Last Min VWAP: $1.06
Company Profile
- Name: Polyrizon Ltd. Ordinary Shares
- Website: https://www.polyrizon-biotech.com
- Listed Date: 2024-10-29
- Location: ,
- Market Status: Active
- CIK Number: 0001893645
- SIC Code:
- SIC description:
- Market Cap: $6.71M
- Round Lot: 100
- Outstanding Shares: 5.99M
- Asset Type: CS
RECENT FILINGS FOR PLRZ
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-14 | 6-K | View |
| 2025-07-31 | 6-K | View |
| 2025-07-24 | S-8 | View |
| 2025-07-22 | 6-K | View |
| 2025-07-15 | 6-K | View |
| 2025-06-30 | 6-K | View |
| 2025-06-12 | 6-K | View |
| 2025-05-23 | 6-K | View |
| 2025-05-22 | 6-K | View |
| 2025-05-21 | 6-K | View |
| 2025-05-19 | 6-K | View |
| 2025-05-14 | 6-K | View |
| 2025-05-12 | EFFECT | View |
| 2025-05-12 | 424B3 | View |
| 2025-05-08 | CORRESP | View |
| 2025-05-07 | UPLOAD | View |
| 2025-05-01 | 6-K | View |
| 2025-05-01 | 6-K | View |
| 2025-04-30 | F-1 | View |
| 2025-04-25 | 6-K | View |
Latest News on PLRZ